Hypergammaglobulinemia classification: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
(11 intermediate revisions by the same user not shown) | |||
Line 6: | Line 6: | ||
==Classification== | ==Classification== | ||
*Hyper IgM associated hypergammaglobulinemias | *Hypergammaglobulinemia may be classified into the following: | ||
**Hyper Ig M associated hypergammaglobulinemias | |||
**Hyper Ig D syndrome | |||
**Hyper Ig E syndrome | |||
*Hyper IgM associated hypergammaglobulinemias are further classified into the following five types:<ref>Hypergammaglobulinemia. Wikipedia. https://en.wikipedia.org/wiki/Hypergammaglobulinemia Accessed on February 24, 2016</ref><ref name=OMIM>Immunodeficiency with hyper-IgM, Type 1; HIGM1. http://www.omim.org/entry/308230. Accessed on February 24, 2016</ref> | |||
{| style="border: 0px; font-size: 90%; margin: 3px; width:650px" | {| style="border: 0px; font-size: 90%; margin: 3px; width:650px" | ||
Line 13: | Line 17: | ||
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF|Type}} | ! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF|Type}} | ||
! style="background: #4479BA; width: 370px;" | {{fontcolor|#FFF|Gene involved}} | ! style="background: #4479BA; width: 370px;" | {{fontcolor|#FFF|Gene involved}} | ||
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF|Mode of inheritance}} | |||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | | ||
Type 1 | Type 1 | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Tumor Necrosis Factor Super Family member 5 (TNFSF5) gene | *Tumor Necrosis Factor Super Family member 5 (''TNFSF5'') gene encoding CD40L | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | | |||
X-linked recessive | |||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" align=center| | | style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" align=center| | ||
Type 2 | Type 2 | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Activation-Induced Cytidine Deaminase (AICDA) gene | *Activation-Induced Cytidine Deaminase (''AICDA'') gene | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | | |||
Autosomal recessive | |||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" align=center| | | style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" align=center| | ||
Type 3 | Type 3 | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*CD40 | *''CD40'' gene | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | | |||
Autosomal recessive | |||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" align=center| | | style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" align=center| | ||
Line 33: | Line 44: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Not yet known | *Not yet known | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | | |||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" align=center| | | style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" align=center| | ||
Type 5 | Type 5 | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *Gene encoding Uracil-DNA glycosylase | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | | |||
Autosomal recessive | |||
|} | |} | ||
Line 46: | Line 61: | ||
*[[Monoclonal gammopathy of undetermined significance]] | *[[Monoclonal gammopathy of undetermined significance]] | ||
{{Immune disorders}} | {{Immune disorders}} | ||
[[Category:Rheumatology]] | [[Category:Rheumatology]] | ||
[[Category:Immunology]] | [[Category:Immunology]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} |
Latest revision as of 18:57, 2 March 2016
Hypergammaglobulinemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hypergammaglobulinemia classification On the Web |
American Roentgen Ray Society Images of Hypergammaglobulinemia classification |
Risk calculators and risk factors for Hypergammaglobulinemia classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Soujanya Thummathati, MBBS [2]
Overview
Classification
- Hypergammaglobulinemia may be classified into the following:
- Hyper Ig M associated hypergammaglobulinemias
- Hyper Ig D syndrome
- Hyper Ig E syndrome
- Hyper IgM associated hypergammaglobulinemias are further classified into the following five types:[1][2]
Type | Gene involved | Mode of inheritance |
---|---|---|
Type 1 |
|
X-linked recessive |
Type 2 |
|
Autosomal recessive |
Type 3 |
|
Autosomal recessive |
Type 4 |
|
|
Type 5 |
|
Autosomal recessive |
References
- ↑ Hypergammaglobulinemia. Wikipedia. https://en.wikipedia.org/wiki/Hypergammaglobulinemia Accessed on February 24, 2016
- ↑ Immunodeficiency with hyper-IgM, Type 1; HIGM1. http://www.omim.org/entry/308230. Accessed on February 24, 2016